Smoking status and endothelial function in Japanese men.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 01 2021
Historique:
received: 26 09 2019
accepted: 10 12 2020
entrez: 9 1 2021
pubmed: 10 1 2021
medline: 14 9 2021
Statut: epublish

Résumé

It is established that smoking is a major risk factor of atherosclerosis. Endothelial dysfunction occurs in the initial step in the pathogenesis of atherosclerosis and plays a critical role in the development of atherosclerosis. The purpose of this study was to evaluate the association between smoking status and endothelial function in detail in men. We measured flow-mediated vasodilation (FMD) in 2209 Japanese men including 1181 men who had never smoked and 1028 current smokers. All of the participants were divided into five groups by smoking pack-years: never smoker group (= 0), light smoker group (> 0 to 10), moderate smoker group (> 10 to 20), heavy smoker group (> 20 to 30) and excessive smoker group (> 30). FMD significantly decreased in relation to pack-years (6.6 ± 3.4% in the never smoker group, 6.8 ± 3.0% in the light smoker group, 6.5 ± 2.9% in the moderate smoker group, 5.9 ± 2.9% in the heavy smoker group, and 4.9 ± 2.7% in the excessive smoker group; P < 0.001). After adjustment for age (≥ 65 years), body mass index, systolic blood pressure, low-density lipoprotein cholesterol, glucose, and year of recruitment, FMD was significantly smaller in the excessive smoker group than in the never smoker group as a reference group (OR 1.95, 95% CI 1.42 to 2.67; P < 0.001). These findings suggest that FMD decreases with an increase in the number of cigarettes smoked and that excessive smoking is associated with endothelial dysfunction. Cigarette smoking is harmful to vascular function in men who are heavy smokers.

Identifiants

pubmed: 33420173
doi: 10.1038/s41598-020-80012-x
pii: 10.1038/s41598-020-80012-x
pmc: PMC7794366
doi:

Substances chimiques

Blood Glucose 0
Cholesterol, LDL 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

95

Références

Circ J. 2009 Mar;73(3):411-8
pubmed: 19194043
Circulation. 1996 Jul 1;94(1):19-25
pubmed: 8964113
Circulation. 1996 Apr 1;93(7):1346-53
pubmed: 8641023
N Engl J Med. 1995 May 4;332(18):1198-203
pubmed: 7700313
Circulation. 1993 Nov;88(5 Pt 1):2149-55
pubmed: 8222109
Diabetes Care. 1999 Jan;22 Suppl 1:S1-114
pubmed: 10333970
Hypertension. 2003 May;41(5):1102-5
pubmed: 12682081
Arterioscler Thromb Vasc Biol. 1996 Apr;16(4):546-52
pubmed: 8624777
N Engl J Med. 1999 Jan 14;340(2):115-26
pubmed: 9887164
Am J Physiol. 1994 Mar;266(3 Pt 2):H874-80
pubmed: 8160834
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
Mass Spectrom Rev. 2014 May-Jun;33(3):183-218
pubmed: 24272816
N Engl J Med. 1996 Jan 18;334(3):150-4
pubmed: 8531969
Circulation. 2003 Jan 28;107(3):416-21
pubmed: 12551865
J Am Coll Cardiol. 2002 Jan 16;39(2):257-65
pubmed: 11788217
Ann Intern Med. 1994 Dec 15;121(12):936-41
pubmed: 7978718
Cardiol Clin. 1996 Feb;14(1):51-68
pubmed: 9072291
Circulation. 2002 Mar 12;105(10):1155-7
pubmed: 11889006
J Am Coll Cardiol. 2017 Jul 11;70(2):230-251
pubmed: 28683970
Int Heart J. 2012;53(3):170-5
pubmed: 22790685
Circulation. 1995 Sep 1;92(5):1094-100
pubmed: 7648652
Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1401-8
pubmed: 23520168
J Am Coll Cardiol. 2010 May 4;55(18):1988-95
pubmed: 20236788
Circulation. 2009 May 5;119(17):2408-16
pubmed: 19364974
Circulation. 2004 Feb 10;109(5):613-9
pubmed: 14769683
J Am Coll Cardiol. 2008 May 20;51(20):1959-64
pubmed: 18482664
Am J Physiol Cell Physiol. 2006 Mar;290(3):C661-8
pubmed: 16469861
J Am Coll Cardiol. 2002 Aug 21;40(4):761-5
pubmed: 12204508
Circulation. 2009 Aug 11;120(6):502-9
pubmed: 19635967
Arch Intern Med. 1999 Apr 12;159(7):733-40
pubmed: 10218754
Heart. 2013 Dec;99(24):1837-42
pubmed: 24153417
Circulation. 2005 Jul 26;112(4):489-97
pubmed: 16027251
J Am Heart Assoc. 2015 Nov 13;4(11):
pubmed: 26567372
PLoS Med. 2006 Nov;3(11):e442
pubmed: 17132052
J Am Coll Cardiol. 2000 Feb;35(2):277-83
pubmed: 10676670
Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2630-5
pubmed: 16210569
Circulation. 1996 Jul 1;94(1):6-9
pubmed: 8964118
J Clin Pharm Ther. 1998 Feb;23(1):1-9
pubmed: 9756105
Chest. 2007 May;131(5):1557-66
pubmed: 17494805
Int J Cardiovasc Imaging. 2010 Aug;26(6):631-40
pubmed: 20339920
Circulation. 1995 Dec 15;92(12):3431-5
pubmed: 8521564
Am J Public Health. 1994 Jul;84(7):1086-93
pubmed: 8017530

Auteurs

Haruki Hashimoto (H)

Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Tatsuya Maruhashi (T)

Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Takayuki Yamaji (T)

Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Takahiro Harada (T)

Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Yiming Han (Y)

Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Yuji Takaeko (Y)

Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Yasuki Kihara (Y)

Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Kazuaki Chayama (K)

Department of Gastroenterology and Metabolism, Institute of Biomedical and Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Chikara Goto (C)

Hiroshima International University, Hiroshima, Japan.

Yoshiki Aibara (Y)

Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Farina Mohamad Yusoff (FM)

Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Shinji Kishimoto (S)

Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Masato Kajikawa (M)

Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Ayumu Nakashima (A)

Department of Stem Cell Biology and Medicine, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.

Yukihito Higashi (Y)

Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. yhigashi@hiroshima-u.ac.jp.
Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan. yhigashi@hiroshima-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH